老年慢性阻塞性肺疾病患者并发心房颤动的危险因素分析及列线图模型构建
Analysis of Risk Factors of Atrial Fibrillation in Elderly Patients with Chronic Obstructive Pulmonary Disease and Nomogram Model Construction
DOI: 10.12677/ACM.2021.113205, PDF,   
作者: 薛晓霞:青岛大学医学部,山东 青岛;刘 璐, 宫 婷:中国人民解放军海军第九七一医院,山东 青岛
关键词: 老年人慢性阻塞性肺疾病心房颤动危险因素列线图The Elderly Chronic Obstructive Pulmonary Disease Atrial Fibrillation Risk Factors Nomogram
摘要: 目的:探讨老年慢性阻塞性肺疾病(Chronic Obstructive Pulmonary Disease, COPD)患者并发心房颤动(Atrial Fibrillation, AF)的独立危险因素,并初步建立老年COPD患者并发AF的列线图风险预测模型。方法:回顾性收集2016年至2020年于某三甲医院住院治疗的老年COPD患者病例资料531例,根据是否发生AF分为COPD并发AF病例组81例和对照患者450例。对两组患者的年龄、性别、吸烟、饮酒等一般情况,高血压病、冠心病、心力衰竭、糖尿病、急性呼吸衰竭、肺部感染、脑卒中、急性心肌梗死、消化道出血以及肾功能不全等合并疾病情况进行统计分析,并使用R语言开发构建列线图预测模型,根据曲线下面积(Area Under Curve, AUC)和Hosmer-Lemeshow (H-L)检验验证模型准确性。结果:两组患者的吸烟、饮酒情况,心力衰竭、糖尿病、急性呼吸衰竭、肺部感染、脑卒中、急性心肌梗死等合并疾病差异有统计学意义(P < 0.05);多因素Logistic回归结果示:心力衰竭(OR = 1.706)、糖尿病(OR = 1.730)、急性呼吸衰竭(OR = 3.408)、肺部感染(OR = 2.859)、脑卒中(OR = 1.662)、急性心肌梗死(OR = 1.204)是老年COPD患者并发AF的独立危险因素。使用R语言开发列线图模型,受试者工作特征曲线下面积AUC为0.809,H-L检验P = 0.35 (P > 0.05),发现该模型的区分度和校准度均较好。结论:心力衰竭、糖尿病、急性呼吸衰竭、肺部感染、脑卒中、急性心肌梗死等合并疾病是老年COPD患者并发AF的独立危险因素。本研究中列线图模型准确度较好,在临床工作中可提供一定的参考。
Abstract: Objective: To investigate the independent risk factors of Atrial Fibrillation (AF) in elderly patients with Chronic Obstructive Pulmonary Disease (COPD), and to establish a nomogram risk prediction model for AF in elderly patients with COPD. Methods: A total of 531 elderly patients with COPD hospitalized in a tertiary hospital from 2016 to 2020 were retrospectively collected. According to the occurrence of AF, they were divided into COPD complicated with AF case group (81 cases) and control group (450 cases). The age, gender, smoking, drinking and other general conditions of the two groups, hypertension, coronary heart disease, heart failure, diabetes, acute respiratory failure, pulmonary infection, stroke, acute myocardial infarction, gastrointestinal bleeding and renal insufficiency were statistically analyzed, and the nomogram prediction model was developed by R language. Area Under Curve (AUC) and Hosmer-Lemeshow (H-L) were used to test the accuracy of the model. Results: There were significant differences in smoking, drinking, heart failure, diabetes, acute respiratory failure, pulmonary infection, stroke, acute myocardial infarction and other comorbid diseases between the two groups (P < 0.05); multivariate logistic regression results showed that: heart failure (OR = 1.706), diabetes (OR = 1.730), acute respiratory failure (OR = 3.408), pulmonary infection (OR = 2.859), heart failure (OR = 1.706), diabetes (OR = 1.730), acute respiratory failure (OR = 3.408), pulmonary infection (OR = 2.859), stroke (OR = 1.662) and acute myocardial infarction (OR = 1.204) were independent risk factors for AF in elderly COPD patients. R language was used to develop the nomogram model. The AUC of the area under the curve was 0.809, and the H-L test was P = 0.35 (P > 0.05). Conclusion: Heart failure, diabetes, acute respiratory failure, pulmonary infection, stroke and acute myocardial infarction are independent risk factors of AF in elderly COPD patients. In this study, the accuracy of nomogram model is good, which can provide some reference in clinical work.
文章引用:薛晓霞, 刘璐, 宫婷. 老年慢性阻塞性肺疾病患者并发心房颤动的危险因素分析及列线图模型构建[J]. 临床医学进展, 2021, 11(3): 1429-1436. https://doi.org/10.12677/ACM.2021.113205

参考文献

[1] January, C.T., Wann, L.S., Alpert, J.S., et al. (2014) 2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation, 130, e199-e267. [Google Scholar] [CrossRef
[2] Wolf, P.A., Abbott, R.D. and Kannel, W.B. (1991) Atrial Fibrillation as an Independent Risk Factor for Stroke: The Framingham Study. Stroke, 22, 983-988. [Google Scholar] [CrossRef
[3] Kirchhof, P., Benussi, S., Kotecha, D., et al. (2016) 2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration with EACTS. European Heart Journal, 37, 2893-2962. [Google Scholar] [CrossRef] [PubMed]
[4] GBD 2017 Mortality Collaborators (2018) Global, Regional, and National Age-Sex-Specific Mortality and Life Expectancy, 1950-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. Lancet, 392, 1684-1735. [Google Scholar] [CrossRef
[5] Adeloye, D., Chua, S., Lee, C., et al. (2015) Global and Regional Estimates of COPD Prevalence: Systematic Review and Meta-Analysis. Journal of Global Health, 5, 20415. [Google Scholar] [CrossRef] [PubMed]
[6] Huang, Q., Xiong, H., Shuai, T., et al. (2020) Risk Factors for New-Onset Atrial Fibrillation in Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. PeerJ, 8, e10376. [Google Scholar] [CrossRef] [PubMed]
[7] Mendez-Bailon, M., Lopez-de-Andres, A., de Miguel-Diez, J., et al. (2017) Chronic Obstructive Pulmonary Disease Predicts Higher Incidence and in Hospital Mortality for Atrial Fibrillation. An Observational Study Using Hospital Discharge Data in Spain (2004-2013). International Journal of Cardiology, 236, 209-215. [Google Scholar] [CrossRef] [PubMed]
[8] Konecny, T., Park, J.Y., Somers, K.R., et al. (2014) Relation of Chronic Obstructive Pulmonary Disease to Atrial and Ventricular Arrhythmias. American Journal of Cardiology, 114, 272-277. [Google Scholar] [CrossRef] [PubMed]
[9] Krijthe, B.P., Kunst, A., Benjamin, E.J., et al. (2013) Projections on the Number of Individuals with Atrial Fibrillation in the European Union, from 2000 to 2060. European Heart Journal, 34, 2746-2751. [Google Scholar] [CrossRef] [PubMed]
[10] Shen, Y.C., Chen, L. and Wen, F.Q. (2018) Interpretation of 2019 Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. Zhonghua Yi Xue Za Zhi, 98, 3913-3916.
[11] Sidney, S., Sorel, M., Quesenberry, C.J., et al. (2005) COPD and Incident Cardiovascular Disease Hospitalizations and Mortality: Kaiser Permanente Medical Care Program. Chest, 128, 2068-2075. [Google Scholar] [CrossRef] [PubMed]
[12] Ferraro, M., Di Vincenzo, S., Dino, P., et al. (2019) Budesonide, Aclidinium and Formoterol in Combination Limit Inflammaging Processes in Bronchial Epithelial Cells Exposed to Cigarette Smoke. Experimental Gerontology, 118, 78-87. [Google Scholar] [CrossRef] [PubMed]
[13] Andreas, S., Anker, S.D., Scanlon, P.D., et al. (2005) Neurohumoral Activation as a Link to Systemic Manifestations of Chronic Lung Disease. Chest, 128, 3618-3624. [Google Scholar] [CrossRef] [PubMed]
[14] Genao, L., Durheim, M.T., Mi, X., et al. (2015) Early and Long-Term Outcomes of Older Adults after Acute Care Encounters for Chronic Obstructive Pulmonary Disease Exacerbation. Annals of the American Thoracic Society, 12, 1805-1812. [Google Scholar] [CrossRef
[15] Buch, P., Friberg, J., Scharling, H., Lange, P. and Prescott, E. (2003) Reduced Lung Function and Risk of Atrial Fibrillation in the Copenhagen City Heart Study. European Respiratory Journal, 21, 1012-1016. [Google Scholar] [CrossRef] [PubMed]
[16] Liao, K.M. and Chen, C.Y. (2017) Incidence and Risk Factors of Atrial Fibrillation in Asian COPD Patients. International Journal of Chronic Obstructive Pulmonary Disease, 12, 2523-2530. [Google Scholar] [CrossRef
[17] Okumura, K., Tomita, H., Nakai, M., et al. (2020) Risk Factors Associated with Ischemic Stroke in Japanese Patients with Nonvalvular Atrial Fibrillation. JAMA Network Open, 3, e202881. [Google Scholar] [CrossRef] [PubMed]
[18] Shibata, Y., Watanabe, T., Osaka, D., et al. (2011) Impairment of Pulmonary Function Is an Independent Risk Factor for Atrial Fibrillation: The Takahata Study. International Journal of Medical Sciences, 8, 514-522. [Google Scholar] [CrossRef] [PubMed]